ClearPoint Neuro Inc [CLPT] stock prices are down -4.61% to $24.83 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CLPT shares have lost -16.11% over the last week, with a monthly amount glided 133.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on October 24, 2023, and set its price target to $8. Lake Street initiated its recommendation with a Buy and recommended $32 as its price target on March 18, 2021. B. Riley FBR started tracking with a Buy rating for this stock on July 17, 2020, and assigned it a price target of $8.
The stock price of ClearPoint Neuro Inc [CLPT] has been fluctuating between $9.76 and $30.10 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. ClearPoint Neuro Inc [NASDAQ: CLPT] shares were valued at $24.83 at the most recent close of the market. An investor can expect a potential drop of -27.51% based on the average CLPT price forecast.
Analyzing the CLPT fundamentals
The ClearPoint Neuro Inc [NASDAQ:CLPT] reported sales of 33.59M for trailing twelve months, representing a surge of 17.27%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -0.67%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.94 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that ClearPoint Neuro Inc [NASDAQ:CLPT]’s Current Ratio is 7.30. On the other hand, the Quick Ratio is 6.45, and the Cash Ratio is 5.62. Considering the valuation of this stock, the price to sales ratio is 21.01, the price to book ratio is 35.75.
Transactions by insiders
Recent insider trading involved BURNETT JOSEPH, CEO and President, that happened on Oct 10 ’25 when 26463.0 shares were sold. Affiliate of Director, JOSEPH M BURNETT TRUST completed a deal on Oct 10 ’25 to buy 26463.0 shares. Meanwhile, Director Richards Timothy T. sold 10000.0 shares on Jun 10 ’25.
